Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol prophylaxis for vestibular migraine
ISRCTN72824329Phase 3Completed
- Sponsor
- LMU Klinikum
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vestibular migraine (VM) comparing Metoprolol with Placebo (2 arms). Primary endpoints: Number of vertigo attacks during the last 3 months of treatment and Number of migraine attacks during the last 3 months of treatment. Started Jan 2010; status: completed.
02
Drugs
metoprolol
03
Conditions
vestibular migraine (VM)
Beyond the preview
Go deeper on ISRCTN72824329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN72824329.